Filing Flows › Nutex Health (NUTX) › Gross margin
Nutex Health (NUTX) gross margin by quarter
Nutex Health's gross margin was 46.7% in Q3 2026 (third quarter 2026), -20.4 pts from Q2 2026. Over the last 7 quarters it ranged from 30.4% (Q4 2025) to 67.0% (Q2 2026).
| Quarter | Gross margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 46.7% | -20.4 pts | -11.2 pts |
| Q2 2026 | 67.0% | +24.7 pts | +15.8 pts |
| Q1 2026 | 42.4% | +12.0 pts | -13.5 pts |
| Q4 2025 | 30.4% | -27.4 pts | — |
| Q3 2025 | 57.8% | +6.6 pts | — |
| Q2 2025 | 51.2% | -4.7 pts | — |
| Q1 2025 | 55.9% | — | — |
Q3 2026 at a glance
Nutex Health, Q3 2026: revenue $218M (-19% year over year), operating margin 35.4%, net earnings $40.2M, operating cash flow $78.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Nutex Health's gross margin?
Nutex Health's gross margin was 46.7% in Q3 2026 (third quarter 2026), -20.4 pts from Q2 2026.
How has Nutex Health's gross margin changed?
Over the last 7 quarters it ranged from 30.4% (Q4 2025) to 67.0% (Q2 2026).